Clients of Chiltern, a Covance company will also have exclusive access to an innovation hub of drug development resources from Covance and LabCorp.
Break through to a new experience. One that gives you access to an exclusive hub of complimentary innovative drug development resources specifically designed for biotech, device and diagnostic firms. One that can save you time and money while adding value to your asset. For example:
►Covance MarketPlace - Capitalize on Your Asset Gain visibility and find the right connection with potential partners, while safeguarding your asset through a unique online networking solution. Your partner may be only a click away.Take a tour.
►Early Phase Development Solutions - Complete Your IND/CTA Program and Move Into the Clinic 30% Faster Advance your program seamlessly from nonclinical through first-in-human with asingle, dedicated teamof drug development experts. It’s one plan possible.
►Consulting Solutions - Optimize Your Product's Value and Pave the Way for Market Success
Accelerate your drug development program with expert insights that advance your program with nonclinical and clinical strategy, medical and regulatory writing or commercialization efforts. Get a comprehensive target product profile (TPP), understand stakeholders and gain a commercial strategy that sets you up for market success.
Regardless of where you are or where you aspire to go in your drug development journey, we can meet you there and accelerate your path forward - with unprecedented continuity. Begin the biotech experience and uncover ways to improve your odds of success: Chiltern.com/TheBioExperience.
Continuity. Dedication. Flexibility. Designed Around You®
Introducing Chiltern, a Covance company: distinct clinical trial solutions for biotech, device and diagnostic ventures
►Chiltern, a Covance company - Get dedicated, agile, collaborative clinical trials
Experience bespoke clinical trialsDesigned Around You® with a dedicated team of experts that bring you deep therapeutic expertise and a rich history of program success – available exclusively for small biotech, device and diagnostic firms.